Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

iSpecimen Q3 EPS $(0.23) Beats $(0.35) Estimate, Sales $2.78M Beat $2.23M Estimate

Author: Benzinga Newsdesk | November 02, 2023 06:40am
iSpecimen (NASDAQ:ISPC) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(0.35) by 34.29 percent. This is a 34.29 percent increase over losses of $(0.35) per share from the same period last year. The company reported quarterly sales of $2.78 million which beat the analyst consensus estimate of $2.23 million by 24.56 percent. This is a 7.54 percent increase over sales of $2.58 million the same period last year.

Posted In: ISPC


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist